Patents by Inventor Alain Hehn

Alain Hehn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230148181
    Abstract: A protein capable of converting chlorogenic acid into isochlorogenic acid. The protein includes or is an amino acid sequence SEQ ID No. 1, a sequence having at least 80% identity with this sequence or a fragment of this sequence. Also, a process for producing isochlorogenic acid from chlorogenic acid, which includes producing the protein and bringing it into contact with chlorogenic acid.
    Type: Application
    Filed: March 12, 2021
    Publication date: May 11, 2023
    Applicants: UNIVERSITE DE LORRAINE, UNIVERSITE DE LILLE, CELLENGO
    Inventors: Frédéric Jean BOURGAUD, Sissi MIGUEL, Aleksander SALWINSKI, Cindy SIGNE, Alain HEHN, Jean-Louis HILBERT, David GAGNEUL, Guillaume LEGRAND
  • Publication number: 20160244771
    Abstract: A method for inhibiting production of furanocoumarins in a plant, includes inhibiting in the plant the expression of a protein named GfPT, the GfPT protein having coumarin-specific prenyltransferase activity and having at least 70% sequence identity with the polypeptide set forth in SEQ ID NO: 1.
    Type: Application
    Filed: February 22, 2016
    Publication date: August 25, 2016
    Inventors: Frederic BOURGAUD, Alain HEHN, Alexandre OLRY, Ryosuke MUNAKATA, Kazufumi YAZAKI, Mazaharu MIZUTANI
  • Patent number: 6303345
    Abstract: Described is the characterization and the use of strong viral promoters for expressing genes, in bacteria and fungi, in particular yeasts. The invention is based on the surprising finding that CFDV DNA (coconut foliar decay virus DNA) and CFDV DNA fragments contain a region which is active as promoter even in bacteria and fungi, in particular yeasts, although they are derived from a virus which infects monocotyledonous plants. The activity of the promoters described in E. coli is distinctly higher than that of the CaMV 35S promoter, which is also active in bacteria.
    Type: Grant
    Filed: May 17, 2000
    Date of Patent: October 16, 2001
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Wolfgang Rohde, Dieter Becker, John W. Randles, Alain Hehn, Francesco Salamini